Enzymatic nucleic acids containing 5'-and/or 3'-cap structures

Details Enzymatic nucleic acids containing 5'-and/or 3'-cap structures Enzymatic nucleic acids containing 5'-and/or 3'-cap structures

1996-04-16

1999-12-07

Degen, Nancy

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

435366, 536 245, 536 253, C07H 2100, C07H 2102, C12N 506, C12N 508

Patent

active

059982039

ABSTRACT:
An enzymatic nucleic acid molecule comprising a 5'- and/or a 3'-cap structure, wherein said structure is not a 5'-5'-linked inverted nucleotide or a 3'-3'-linked inverted nucleotide.

REFERENCES:
patent: 4987071 (1991-01-01), Cech et al.
patent: 5246921 (1993-09-01), Reddy et al.
patent: 5256775 (1993-10-01), Froehler
patent: 5334711 (1994-08-01), Sproat et al.
patent: 5610054 (1997-03-01), Draper
patent: 5646042 (1997-07-01), Stinchcomb et al.
patent: 5672511 (1997-09-01), Beigelman et al.
Concise Encyclopedia Chemistry, Eagleson, trans. Walter De Gruyter, New York, p. 541, 1994.
Gura "Antisense has growing pains" Science 270: 575-577, Oct. 1995.
Stull et al. Antigene, ribozyme, and aptamer nucleic acid drugs: Progress and prospects. Pharm. Res. 12(4):465-483, Apr. 1995.
Watson et al. Molecular B8iology of the Gene, fourth edition. The Benjamin/Cummings Publishing Company, Reading Mass, pp. 568-569, 1987.
Beaucage and Iyer, "The Synthesis of Modified Oligonucleotides by the Phosphoramidite Approach and Their Applications," Tetrahedron Lett. 49:6123-6194 (1993).
Beigelman et al., "Chemical Modification of Hammerhead Ribozymes," J. Biol. Chem. 270:25702-25708 (1995).
Cech, "Ribozymes and Their Medical Implications," JAMA 260:3030-3034 (1988).
Christoffersen and Marr, "Ribozymes as Human Therapeutic Agents," J. Med. Chem. 38:2023-2037 (1995).
Gryaznov and Letsinger, "Synthesis and properties of oligonucleotides containing aminodeoxythymidine units," Nucleic Acids Research 20:3403-3409 (1992).
Guerrier-Takada et al., "The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme," Cell 35:849-857 (1983).
Hampel et al., "`Hairpin` Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA," Nucleic Acids Research 18:299-304 (1990).
Hampel and Tritz, "RNA Catalytic Properties of the Minimum(-)sTRSV Sequence," Biochemistry 28:4929-4933 (1989).
Haseloff and Gerlach, "Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities," Nature 334:585-591 (1988).
Heidenreich et al., "Chemically modified RNA: approaches and applications," FASEB J. 7:90-96 (1993).
Jeffries and Symons, "A Catalytic 13-mer Ribozyme," Nucleic Acids Research 17:1371-1377 (1989).
Kim and Cech, "Three-dimensional model of the active site of the self-splicing rRNA precursor of Tetrahymena," Proc. Natl. Acad. Sci. USA 84:8788-8792 (1987).
Letsinger and Mungall, "Phosphoramidate Analogs of Oligonucleotides," J. Org. Chem. 35:3800-3803 (1970).
Lyngstadaas et al., "A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo," EMBO J. 14:5224 (1995).
Moffatt, "Chemical Transformation of the Sugar Moiety of Nucleosides," in Nucleoside Analogues: Chemistry, Biology and Medical Applications, Walker et al. eds., Plenum Press, New York, pp. 71-164 (1979).
Perreault et al., "Mixed Deoxyribo- and Ribo-Oligonucleotides with Catalytic Activity," Nature 344:565-567 (1990).
Perrotta and Been, "Cleavage of Oligoribonucleotides by a Ribozyme Derived from the Hepatitis .delta. Virus RNA Sequence," Biochemistry 31:16-21 (1992).
Pieken et al., "Kinetic Characterization of Ribonuclease-Resistant 2'-Modified Hammerhead Ribozymes," Science 253:314-317 (1991).
Rossi et al, "Ribozymes as Anti-HIV-1 Therapeutic Agents: Principles, Applications, and Problems," Aids Research and Human Retroviruses 8:183-189 (1992).
Saville and Collins, "A Site-Specific Self-Cleavage Reaction Performed by a Novel RNA In Neurospora Mitochondria," Cell 61:685-696 (1990).
Saville and Collins, "RNA-Mediated Ligation of Self-Cleavage Products of a Neurospora Mitochondrial Plasmid Transcript," Proc. Natl. Acad. Sci. USA 88:8826-8830 (1991).
Scaringe et al., "Chemical synthesis of biologically active oligoribonucleotides using .beta.-cyanoethyl protected ribonucleoside phosphoramidites," Nucl Acids Res. 18:5433-5441 (1990).
Seliger, "New Developments in the Field of Antisense Oligonucleotides," Prog. Biotechnol. 1994 (9) ECB6: Proceedings of the 6th European Congress on Biotechnology, Jun. 13-17, 1993 (Pt. 2).
Sproat et al., "The synthesis of protected 5'-mercapto-2',5'-dideoxyribonucleoside-3'-O-phosphoramidites; uses of 5'-mercapto-oligodeoxyribonucleotides," Nucleic Acids Research 15:4837-4848 (1987).
Uhlenbeck, "A Small Catalytic Oligoribonucleotide," Nature 328:596-600 (1987).
Usman and Cedergren, "Exploiting the chemical synthesis of RNA," TIBS 17:334-339 (1992).
Usman et al., "Automated Chemical Synthesis of Long Oligoribonucleotides Using 2'-O-Silylated Ribonucleoside 3'-O-Phosphoramidites on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleotide Sequence Similar to the 3'-Half Molecule of an Escherichia coli Formylmethoionine tRNA," J. Am. Chem. Soc. 109:7845-7854 (1987).
Usman and McSwiggen, "Ch. 30--Catalytic RNA (Ribozymes) as Drugs," Ann. Rep. Med. Chem. 30:285-294 (1995).
Wincott et al., "Synthesis, deprotection, analysis and purification of RNA and ribozymes," Nucleic Acids Research 23:2677-2684 (1995).
Zaug et al., "The Tetrahymena Ribozyme Acts Like an RNA Restriction Endonuclease," Nature 324:429-433 (1986).

Affiliated with

Also associated with

Rating

Enzymatic nucleic acids containing 5'-and/or 3'-cap structures does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzymatic nucleic acids containing 5'-and/or 3'-cap structures, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzymatic nucleic acids containing 5'-and/or 3'-cap structures will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-822751